Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
UBS
Daiichi Sankyo
Harvard Business School
Fuji
Accenture
Medtronic
Queensland Health

Generated: August 17, 2018

DrugPatentWatch Database Preview

FERRIPROX Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Ferriprox, and what generic alternatives are available?

Ferriprox is a drug marketed by Apopharma Inc and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has forty-two patent family members in twenty-four countries.

The generic ingredient in FERRIPROX is deferiprone. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the deferiprone profile page.

Drug patent expirations by year for FERRIPROX
Generic Entry Opportunity Date for FERRIPROX
Generic Entry Dates for FERRIPROX*:
Constraining patent/regulatory exclusivity:
TREATMENT OF PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD DUE TO THALASSEMIA SYNDROMES WHEN CURRENT CHELATION THERAPY IS INADEQUATE
NDA:
Dosage:
SOLUTION;ORAL
Generic Entry Dates for FERRIPROX*:
Constraining patent/regulatory exclusivity:
TREATMENT OF PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD DUE TO THALASSEMIA SYNDROMES WHEN CURRENT CHELATION THERAPY IS INADEQUATE
NDA:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for FERRIPROX
Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity
Synonyms for FERRIPROX
1,2-dimethyl-3-hydroxy-4-pyridinone
1,2-dimethyl-3-hydroxy-4-pyridone
1,2-Dimethyl-3-hydroxy-4-pyridone, 99+%
1,2-DIMETHYL-3-HYDROXY-4-PYRIDONE,99+%
1,2-Dimethyl-3-hydroxy-4(1H)-pyridinone
1,2-Dimethyl-3-hydroxypyrid-4-one
1,2-Dimethyl-3-hydroxypyridine-4-one
1,2-dimetyl-3-hydroxy-4-pyridinone
2BTY8KH53L
3-HYDROXY-1,2-DIMETHYL-4 -PYRIDONE
3-hydroxy-1,2-dimethyl-4- pyridinone
3-Hydroxy-1,2-dimethyl-4-pyridinone
3-hydroxy-1,2-dimethyl-4(1H)-pyridinone
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone, 98%
3-Hydroxy-1,2-dimethyl-4(1H)pyridinone
3-hydroxy-1,2-dimethyl-pyridin-4-one
3-hydroxy-1,2-dimethylhydropyridin-4-one
3-hydroxy-1,2-dimethylpyrid-4-one
3-hydroxy-1,2-dimethylpyridin-4-one
3-hydroxy-1,2-dimethylpyridin-4(1H)-one
30652-11-0
3231AB
4(1H)-Pyridinone, 1,2-dimethyl-3-hydroxy-
4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl-
4(1H)-Pyridone, 3-hydroxy-1,2-dimethyl-
4(1H)-Pyridone, 3-hydroxy-1,2-dimethyl- (8CI)
AB00572605_11
AB00572605_12
AC1L1EVW
AC1Q3YW0
ACMC-209hhl
AJ-08273
AK112338
AKOS015902286
ANW-26935
API0002235
APO-066
APO-66
AX8010603
BB_SC-12066
BP-12415
BRN 1447108
C-01884
CAS-30652-11-0
CC-02933
CCG-100760
CCRIS 8318
CGP-37391
CHEBI:68554
CHEMBL70927
CP020
CP20
CP20 (Chelating agent)
CPD000059136
CRMD-001
CS-5240
D07416
D0N0OU
DB-047826
DB08826
deferione
deferiprone
deferiprone (dfp)
Deferiprone (INN)
Deferiprone (USAN/INN)
Deferiprone [BAN:INN]
Deferiprone [USAN:INN:BAN]
Deferum
DN-180-01-AF
DSSTox_CID_20666
DSSTox_GSID_40666
DSSTox_RID_79529
DTXSID6040666
EX-A972
FCH1115379
Ferriprox (TN)
FT-0606424
GTPL7456
HE000683
HE196248
HK-1
HMS2051C05
HMS2232E24
HMS3264P17
HMS3393C05
HSDB 8335
HY-B0568
I14-13353
InChI=1/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3
KB-32094
KS-00000FAB
L-1[chelating agent]
L1
LS-133035
MCULE-6406005067
MFCD00134497
MLS000069481
MLS000758227
MLS001424029
MLS006011689
MolPort-001-792-505
NC00010
NCGC00090548-01
NCGC00090548-02
NSC-758880
NSC758880
Opera_ID_366
Pharmakon1600-01504512
PL1
s4067
SAM001247015
SBB006753
SBI-0207041.P001
SC-16614
SCHEMBL94474
SMR000059136
ST093416
ST24028539
TC-115680
Tox21_112429
TRA0004923
TZXKOCQBRNJULO-UHFFFAOYSA-
TZXKOCQBRNJULO-UHFFFAOYSA-N
UNII-2BTY8KH53L
VP13942
ZB000634
ZINC6226

US Patents and Regulatory Information for FERRIPROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-002 Apr 20, 2018 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Apopharma Inc FERRIPROX deferiprone SOLUTION;ORAL 208030-001 Sep 9, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apopharma Inc FERRIPROX deferiprone TABLET;ORAL 021825-001 Oct 14, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apopharma Inc FERRIPROX deferiprone TABLET;ORAL 021825-001 Oct 14, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Paragraph IV (Patent) Challenges for FERRIPROX
Drugname Dosage Strength RLD Date
➤ Subscribe Tablets 500 mg ➤ Subscribe ➤ Try a Free Trial

see a sample report or, see our see our flat-rate plans

International Patents for FERRIPROX

Country Document Number Estimated Expiration
Denmark 1294379 ➤ Try a Free Trial
World Intellectual Property Organization (WIPO) 0202114 ➤ Try a Free Trial
Serbia 53689 ➤ Try a Free Trial
Austria 427107 ➤ Try a Free Trial
Spain 2324978 ➤ Try a Free Trial
Eurasian Patent Organization 022751 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Citi
Covington
Teva
Cantor Fitzgerald
Accenture
US Department of Justice
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.